Aanvaard alle cookies en geniet van de beste ervaring op onze website, zoals contentpersonalisatie en functies voor social media. Aanvaard enkel noodzakelijke cookies en ga voor minimaal gebruik van cookies terwijl je browst. Dit betekent wel dat sommige delen van de website mogelijk niet correct worden weergeven. Meer weten? Raadpleeg ons Privacybeleid.
With the impending implementation of the EMA’s ISO IDMP, life sciences organizations will need to ensure they maintain compliance. In a recent article for Pharma Technology Focus, Amplexor’s Siniša Belina explores practical ways in which such organizations can do so.
Author Bio
Siniša is a Senior Life Sciences Consultant within the Product Management team. He applies his detailed knowledge of pharmaceutical processes and documentation to the areas of business process analysis, optimization of software solutions and demonstration of their capabilities. He started his professional career at Pliva (now the TEVA Group), where in addition to his responsibilities in manufacturing, he engaged in a successful EDMS implementation project. He later joined KRKA’s Regulatory Affairs Department, and finally moved to Amplexor in 2008. Siniša received his Bachelor of Science degree in Pharmacy from Zagreb University.